Triglyceride-rich lipoprotein cholesterol
lipoproteinTriglyceride-rich lipoprotein cholesterol is an atherogenic lipoprotein fraction that independently predicts atherosclerotic cardiovascular disease.
Pathway placement
Cascade stepLipid retention & oxidation
Confidencemedium
RationaleASCVD and MI risk stratification; atherogenic lipoprotein subclass.
Druggability
Not assessed (no mapped human gene target).
Assay & specimen
Specialized reference method
Specimen
Serum or plasma (EDTA)
Collection tube
K2/K3-EDTA (lavender-top) · Serum separator (gold/red-top, SST)
Method / principle
NMR lipoprotein particle analysis or density-gradient ultracentrifugation
Reagent / substrate
No chemical reagent — NMR spectral deconvolution of lipid methyl signals (or ultracentrifugal separation by density)
Platform
NMR (LabCorp NMR LipoProfile) / analytical ultracentrifuge
Turnaround · availability
Send-out · Specialized reference lab
Literature evidence(2)
- Fenofibrate plus statin and ASCVD risk by triglyceride-rich lipoprotein cholesterol in 70,000 patients.Journal of lipid research · 2026 · PMID 41881263 · doi
- Triglyceride-rich lipoproteins cholesterol, 10-years atherosclerotic cardiovascular disease risk, and risk of myocardial infarction and ischemic stroke.Journal of lipid research · 2024 · PMID 39307396 · doi